Marijuana is no longer an illicit substance confined to dark alley exchanges. Now that marijuana is legal in Maryland, it is part of a regulated market with widespread accessibility. While the economic and medical potential of legal cannabis is undeniable, there’s a growing need to shine a light on the lesser-known risks associated with its use, particularly Cannabis Use Disorder in Maryland, a condition becoming more visible in the population.

This article dives deep into the Maryland cannabis data and surfaces key concerns around cannabis use disorder, cannabis hyperemesis syndrome, and rising incidents of accidental ingestion among children. With striking insights from expert studies, we aim to help readers better understand the realities of cannabis post-legalisation in Maryland.

What is Cannabis Use Disorder?

Cannabis Use Disorder, abbreviated as CUD, refers to the inability to control cannabis use despite its negative consequences on personal, physical, or psychological well-being. A recent survey conducted by Maryland officials reveals a concerning rise in the prevalence of cannabis addiction among adults, particularly in the 26–45 age group.

Insights from the Maryland Medical Cannabis Patient Survey

According to the 2024 Maryland Medical Cannabis Patient Survey, over 4,400 respondents met the criteria for CUD, marking a 3% increase from the previous year. Startlingly, more than half of those affected were women, highlighting a demographic shift worth analysing further.

The criteria for diagnosing CUD include:

• Spending excessive time acquiring, using, or recovering from cannabis.
• Continued use despite cannabis causing interpersonal or health problems.
• An inability to reduce usage despite concerted efforts.

Dr Bernard Ravitz, an addiction medicine specialist in Maryland, said, “There is a fine line between misuse and abuse. Once misuse progresses to abuse, you’re likely meeting the threshold for CUD.”

Experiencing these symptoms may indicate a dependency issue, and it’s critical for individuals with these patterns to seek guidance from medical professionals.

Cannabis Hyperemesis Syndrome in Maryland

Beyond CUD, there’s another overlooked condition linked to cannabis use. Known as Cannabis Hyperemesis Syndrome (CHS), this condition is characterised by cyclic vomiting and abdominal pain caused by prolonged or heavy cannabis use. While largely underreported globally, Maryland data offers insight into its prevalence.

Who is Most Affected by CHS

The Maryland survey reveals that 2% of cannabis users reported symptoms of CHS, totalling about 200 respondents. Those most affected were people aged 26 to 35 years old, followed closely by those aged 36–45. This data suggests younger adults are more susceptible, possibly due to higher usage rates.

Dr Ravitz explained, “Frequent visitors diagnosed with CHS often show up at emergency rooms here in Maryland. Treatment typically includes IV fluids and antiemetics to relieve nausea and vomiting.”

Cannabis and Risks to Children

While concerns regarding adults tend to dominate public discourse, data shows children are becoming unintended victims of legal cannabis products. Accidental ingestion of cannabis edibles is an alarming trend in Maryland.

Accidental Exposure Among Children

The Maryland Cannabis Administration’s recent Biannual Study disclosed an 80-call decrease to poison control centres compared to 2023, yet calls involving children aged five or younger have risen by a worrying 35% over the same period.

Dr Ravitz raised this critical concern, saying, “The issue arises from cannabis edibles looking like regular candy. These child-friendly appearances increase cases of accidental ingestion among kids.”

Parents and caregivers in Maryland must stay vigilant and store cannabis products securely.

Maryland’s Legislative Attempts for Cannabis Awareness

Maryland’s state agencies are taking steps to address these challenges. The Cannabis Public Health Advisory Council, formed in 2022, is working on policies aimed at youth prevention, public education, and labelling guidelines for cannabis products.

At its recent public meeting, the council emphasised the need for continued studies into cannabis’ long-term effects on minors, particularly concerning their developing brains. Since cannabis-related lobbying often raises parallels with the big alcohol and tobacco industries, Maryland aims to learn from past mistakes to craft policies promoting public health.

Dr Ravitz remained cautious yet optimistic, stating, “While cannabis is more mainstream now, we must focus on prevention strategies. Public education and safeguards are key to managing its impact responsibly.”

Why Maryland Needs More Education and Research

The legalisation wave is often accompanied by the misconception that cannabis is entirely harmless. The Maryland data, however, suggests otherwise. From the increasing risks of cannabis use disorder to the quiet emergence of cannabis hyperemesis syndrome and child-focused accidents, it’s evident Maryland has work to do to mitigate these public health issues.

Education campaigns about responsible cannabis use, community programmes, and vigilant state policies are essential. Parents and users must stay informed about the risks to protect themselves and their loved ones.

Source: AFRO